Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 4, 2015, Pages 4008-4014

  Shi, Xiao Min ^a   Teng, Fei ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Invasion; LncRNA Sox2ot; Migration; Prognosis

Indexed keywords

LONG NON-CODING RNA SOX2OT, HUMAN; LONG UNTRANSLATED RNA; TUMOR MARKER;

CANCER GRADING; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEP-G2 CELL LINE; HUMAN; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; RNA INTERFERENCE; SECONDARY; TIME FACTOR; TREATMENT OUTCOME; TUMOR INVASION; UPREGULATION;

BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; RNA INTERFERENCE; RNA, LONG NONCODING; TIME FACTORS; TRANSFECTION; TREATMENT OUTCOME; UP-REGULATION;

EID: 84935456686     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Qi P, Cheng SQ, Wang H, Li N, Chen YF and Gao CF. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 2011; 6: e28486.
2. Tsai WL and Chung RT. Viral hepatocarcinogenesis. Oncogene 2010; 29: 2309-2324.
3. Bruix J and Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
4. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroen- terology 2012; 142: 1264-1273 e1261.
5. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57-74.
6. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-874.
7. Batista PJ and Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell 2013; 152: 1298-1307.
8. Sanchez Y and Huarte M. Long non-coding RNAs: challenges for diagnosis and therapies. Nucleic Acid Ther 2013; 23: 15-20.
9. Prensner JR and Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov 2011; 1: 391-407.
10. Gibb EA, Brown CJ and Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011; 10: 38.
11. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S and Chang HY. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-1076.
12. Zhang HM, Yang FQ, Yan Y, Che JP and Zheng JH. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma. Int J Clin Exp Pathol 2014; 7: 5801-9.
13. Sun M, Jin FY, Xia R, Kong R, Li JH, Xu TP, Liu YW, Zhang EB, Liu XH and De W. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer 2014; 14: 319.
14. Ma MZ, Kong X, Weng MZ, Zhang MD, Qin YY, Gong W, Zhang WJ and Quan ZW. Long noncoding RNALET is a positive prognostic factor and exhibits-tumorsuppressive activity in gallbladder cancer. Mol Carcinog 2014; [Epub ahead of print].
15. Llovet JM and Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008; 48: 1312-1327.
16. Maruyama R and Suzuki H. Long noncoding RNA involvement in cancer. BMB Rep 2012; 45: 604-611.
17. Graham V, Khudyakov J, Ellis P and Pevny L. SOX2 functions to maintain neural progenitor identity. Neuron 2003; 39: 749-765.
18. Liu K, Lin B, Zhao M, Yang X, Chen M, Gao A, Liu F, Que J and Lan X. The multiple roles for Sox2 in stem cell maintenance and tumorigenesis. Cell Signal 2013; 25: 1264-1271.
19. Askarian-Amiri ME, Seyfoddin V, Smart CE, Wang J, Kim JE, Hansji H, Baguley BC, Finlay GJ and Leung EY. Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancer. PLoS One 2014; 9: e102140.
20. Shahryari A, Rafiee MR, Fouani Y, Oliae NA, Samaei NM, Shafiee M, Semnani S, Vasei M and Mowla SJ. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma. Stem Cells 2014; 32: 126-134.
21. Hou Z, Zhao W, Zhou J, Shen L, Zhan P, Xu C, Chang C, Bi H, Zou J, Yao X, Huang R, Yu L and Yan J. A long noncoding RNA Sox2ot regulates lung cancer cell proliferation and is a prognostic indicator of poor survival. Int J Biochem Cell Biol 2014; 53: 380-388.